Treponema pallidum Repeat (tpr) Genes and Antigenic Variation

Chapter

Abstract

In the absence of treatment, syphilis is a lifelong infection with clinically manifest stages that alternate with periods of latency. The primary and secondary stages of the disease are highly infectious in that the agent of syphilis, Treponema pallidum subsp. pallidum (T. pallidum), actively proliferates in the lesions that stigmatize early syphilis (such as the primary “chancre”, and the secondary mucosal lesions and skin rash). Within these lesions, however, the increasing bacterial burden elicits a robust immune response that culminates with the immune clearance of the great majority of the treponemes and allows spontaneous lesion resolution. Nonetheless, very few treponemes successfully evade the host’s immune response and latently persist in the affected individual for decades. Eventually, in approximately one third of the patients, the disease reactivates leading to the dreaded manifestations of tertiary syphilis, such as insanity, blindness, paralysis, or death. How some T. pallidum cells can successfully evade the host defenses is a key question mark in syphilis pathogenesis. A variety of mechanisms were proposed over the last three decades, including residence of the pathogen within intracellular or immune privileged niches, or its ability to cloak its surface with host proteins or mucopolysaccharides to disguise as “self” and avoid immune recognition. Although not abandoned, the strength of the above theories was significantly lessened by the discovery of phase variation mechanisms for four hypothetical outer membrane proteins (OMPs) candidates encoded by the T. pallidum tpr (T. pallidum repeat) gene family, and the demonstration that the variable antigen TprK is involved in treponemal immune selection during experimental infection. Such findings strongly suggest a role for some tpr genes in immune evasion and persistence. After one century from the isolation of the first T. pallidum strain in 1912 by Nichols and Hough, progress to elucidate the molecular mechanisms behind T. pallidum’s persistence is still hindered by the inability to grow in vitro or genetically manipulate T. pallidum, the pathogen’s limited viability outside of a host, and an uncommonly fragile cellular ultrastructure. Despite such limitations, much evidence support that immune evasion by the syphilis spirochete is based on sophisticated molecular strategies whose investigation could significantly deepen our understanding of syphilis pathogenesis and also favor the identification of broadly protective vaccines.

Keywords

Hepatitis Mercury Europe Attenuation Recombination 

References

  1. Arrizabalaga J, Henderson J, French R (1997) The great Pox: the French disease in renaissance Europe. Yale University Press, New HavenGoogle Scholar
  2. Baker-Zander S, Sell S (1980) A histopathologic and immunologic study of the course of syphilis in the experimentally infected rabbit. Demonstration of long-lasting cellular immunity. Am J Pathol 101(2):387–414PubMedGoogle Scholar
  3. Barrett LG, Thrall PH, Burdon JJ, Linde CC (2008) Life history determines genetic structure and evolutionary potential of host-parasite interactions. Trends Ecol Evol 23(12):678–685PubMedCrossRefGoogle Scholar
  4. Baughn RE, Musher DM (2005) Secondary syphilitic lesions. Clin Microbiol Rev 18(1):205–216PubMedCrossRefGoogle Scholar
  5. Bayliss CD, Dixon KM, Moxon ER (2004) Simple sequence repeats (microsatellites): mutational mechanisms and contributions to bacterial pathogenesis. A meeting review. FEMS Immunol Med Microbiol 40(1):11–19PubMedCrossRefGoogle Scholar
  6. Brinkman MB, McGill MA, Pettersson J, Rogers A, Matejkova P, Smajs D, Weinstock GM, Norris SJ, Palzkill T (2008) A novel Treponema pallidum antigen, TP0136, is an outer membrane protein that binds human fibronectin. Infect Immun 76(5):1848–1857PubMedCrossRefGoogle Scholar
  7. Cameron CE (2003) Identification of a Treponema pallidum laminin-binding protein. Infect Immun 71(5):2525–2533PubMedCrossRefGoogle Scholar
  8. Cameron DJ (2008) An appraisal of “chronic Lyme disease” [comment]. N Engl J Med 358(4):429–430, author reply 430–421PubMedGoogle Scholar
  9. Cameron CE, Lukehart SA, Castro C, Molini B, Godornes C, Van Voorhis WC (2000) Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92. J Infect Dis 181(4):1401–1413PubMedCrossRefGoogle Scholar
  10. Cameron CE, Brown EL, Kuroiwa JM, Schnapp LM, Brouwer NL (2004) Treponema pallidum fibronectin-binding proteins. J Bacteriol 186(20):7019–7022PubMedCrossRefGoogle Scholar
  11. CDC (2007) Sexually transmitted disease surveillance, 2006. US. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GAGoogle Scholar
  12. Centurion-Lara A, Castro C, Barrett L, Cameron C, Mostowfi M, Van Voorhis WC, Lukehart SA (1999) Treponema pallidum major sheath protein homologue Tpr K is a target of opsonic antibody and the protective immune response. J Exp Med 189(4):647–656PubMedCrossRefGoogle Scholar
  13. Centurion-Lara A, Sun ES, Barrett LK, Castro C, Lukehart SA, Van Voorhis WC (2000) Multiple alleles of Treponema pallidum repeat gene D in Treponema pallidum isolates. J Bacteriol 182(8):2332–2335PubMedCrossRefGoogle Scholar
  14. Centurion-Lara A, LaFond RE, Hevner K, Godornes C, Molini BJ, Van Voorhis WC, Lukehart SA (2004) Gene conversion: a mechanism for generation of heterogeneity in the tprK gene of Treponema pallidum during infection. Mol Microbiol 52(6):1579–1596PubMedCrossRefGoogle Scholar
  15. Centurion-Lara A, Molini BJ, Godornes C, Sun E, Hevner K, Van Voorhis WC, Lukehart SA (2006) Molecular differentiation of Treponema pallidum subspecies. J Clin Microbiol 44(9):3377–3380PubMedCrossRefGoogle Scholar
  16. Chapel TA (1978) The variability of syphilitic chancres. Sex Transm Dis 5(2):68–70PubMedCrossRefGoogle Scholar
  17. Chapel TA (1980) The signs and symptoms of secondary syphilis. Sex Transm Dis 7(4):161–164PubMedCrossRefGoogle Scholar
  18. Chapel TA (1988) Congenital syphilis. Compr Ther 14(3):25–28PubMedGoogle Scholar
  19. Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS, Cohen MS (2007) Syphilis in China: results of a national surveillance programme. Lancet 369(9556):132–138PubMedCrossRefGoogle Scholar
  20. Cox DL, Chang P, McDowall AW, Radolf JD (1992) The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun 60(3):1076–1083PubMedGoogle Scholar
  21. Cox DL, Luthra A, Dunham-Ems S, Desrosiers DC, Salazar JC, Caimano MJ, Radolf JD (2010) Surface immunolabeling and consensus computational framework to identify candidate rare outer membrane proteins of Treponema pallidum. Infect Immun 78(12):5178–5194PubMedCrossRefGoogle Scholar
  22. Craig AG, Scherf A (2003) Antigenic variation. Academic, BostonGoogle Scholar
  23. Cumberland MC, Turner TB (1949) The rate of multiplication of Treponema pallidum in normal and immune rabbits. Am J Syph Gonorrhea Vener Dis 33(3):201–212PubMedGoogle Scholar
  24. Cunningham TM, Walker EM, Miller JN, Lovett MA (1988) Selective release of the Treponema pallidum outer membrane and associated polypeptides with Triton X-114. J Bacteriol 170(12):5789–5796PubMedGoogle Scholar
  25. Deitsch KW, Lukehart SA, Stringer JR (2009) Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat Rev Microbiol 7:493–503PubMedCrossRefGoogle Scholar
  26. Desrosiers DC, Anand A, Luthra A, Dunham-Ems SM, Ledoyt M, Cummings MA, Eshghi A, Cameron CE, Cruz AR, Salazar JC et al (2011) TP0326, a Treponema pallidum beta-barrel assembly machinery A (BamA) orthologue and rare outer membrane protein. Mol Microbiol 80(6):1496–1515PubMedCrossRefGoogle Scholar
  27. Diamond J (1997) Guns, germs and steel. W.W. Norton, New YorkGoogle Scholar
  28. DiCarlo RP, Martin DH (1997) The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 25(2):292–298PubMedCrossRefGoogle Scholar
  29. Dornberger U, Leijon M, Fritzsche H (1999) High base pair opening rates in tracts of GC base pairs. J Biol Chem 274(11):6957–6962PubMedCrossRefGoogle Scholar
  30. Fenno JC, Muller KH, McBride BC (1996) Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola. J Bacteriol 178(9):2489–2497PubMedGoogle Scholar
  31. Fenno JC, Wong GW, Hannam PM, Muller KH, Leung WK, McBride BC (1997) Conservation of msp, the gene encoding the major outer membrane protein of oral Treponema spp. J Bacteriol 179(4):1082–1089PubMedGoogle Scholar
  32. Finlay BB, Falkow S (1997) Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 61(2):136–169PubMedGoogle Scholar
  33. Fiumara NJ (1975) Syphilis in newborn children. Clin Obstet Gynecol 18(1):183–189PubMedCrossRefGoogle Scholar
  34. Fiumara NJ, Berg M (1974) Primary syphilis in the oral cavity. Br J Vener Dis 50(6):463–464PubMedGoogle Scholar
  35. Foa A (1990) The new and the old: the spread of syphilis (1494–1530). In: Muir E, Ruggiero G (eds) Sex and gender in historical perspective. Johns Hopkins University Press, BaltimoreGoogle Scholar
  36. Gerbase AC, Rowley JT, Heymann DH, Berkely SF, Piot P (1998) Global prevalence and incidence estimates of selected curable STDs. Sex Transm Infect 74(Suppl 1):S12–S16PubMedGoogle Scholar
  37. Giacani L, Sambri V, Marangoni A, Cavrini F, Storni E, Donati M, Corona S, Lanzarini P, Cevenini R (2005a) Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum. Infect Immun 73(6):3817–3822PubMedCrossRefGoogle Scholar
  38. Giacani L, Hevner K, Centurion-Lara A (2005b) Gene organization and transcriptional analysis of the tprJ, tprI, tprG and tprF loci in the Nichols and Sea 81–4 Treponema pallidum isolates. J Bacteriol 187(17):6084–6093PubMedCrossRefGoogle Scholar
  39. Giacani L, Molini B, Godornes C, Barrett L, Van Voorhis WC, Centurion-Lara A, Lukehart SA (2007a) Quantitative analysis of tpr gene expression in Treponema pallidum isolates: differences among isolates and correlation with T-cell responsiveness in experimental syphilis. Infect Immun 75(1):104–112PubMedCrossRefGoogle Scholar
  40. Giacani L, Lukehart S, Centurion-Lara A (2007b) Length of guanosine homopolymeric repeats modulates promoter activity of Subfamily II tpr genes of Treponema pallidum ssp. pallidum. FEMS Immunol Med Microbiol 51:289–301PubMedCrossRefGoogle Scholar
  41. Giacani L, Godornes C, Puray-Chavez M, Guerra-Giraldez C, Tompa M, Lukehart SA, Centurion-Lara A (2009) TP0262 is a modulator of promoter activity of tpr Subfamily II genes of Treponema pallidum ssp. pallidum. Mol Microbiol 72(5):1087–1099PubMedCrossRefGoogle Scholar
  42. Giacani L, Jeffrey BM, Molini BJ, Le HT, Lukehart SA, Centurion-Lara A, Rockey DD (2010a) Complete genome sequence and annotation of the Treponema pallidum subsp. pallidum Chicago strain. J Bacteriol 192(10):2645–2646PubMedCrossRefGoogle Scholar
  43. Giacani L, Molini BJ, Kim EY, Godornes BC, Leader BT, Tantalo LC, Centurion-Lara A, Lukehart SA (2010b) Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis. J Immunol 184(7):3822–3829PubMedCrossRefGoogle Scholar
  44. Gjestland T (1955) The Oslo study of untreated syphilis. Acta Derm Venereol 35(Suppl):11–368Google Scholar
  45. Handsfield HH, Lukehart SA, Sell S, Norris SJ, Holmes KK (1983) Demonstration of Treponema pallidum in a cutaneous gumma by indirect immunofluorescence. Arch Dermatol 119(8):677–680PubMedCrossRefGoogle Scholar
  46. Hardy PH Jr, Levin J (1983) Lack of endotoxin in Borrelia hispanica and Treponema pallidum. Proc Soc Exp Biol Med 174(1):47–52PubMedGoogle Scholar
  47. Hira SK, Patel JS, Bhat SG, Chilikima K, Mooney N (1987) Clinical manifestations of secondary syphilis. Int J Dermatol 26(2):103–107PubMedCrossRefGoogle Scholar
  48. Hook EW III, Marra CM (1992) Acquired syphilis in adults. N Engl J Med 326(16):1060–1069PubMedCrossRefGoogle Scholar
  49. Hourihan M, Wheeler H, Houghton R, Goh BT (2004) Lessons from the syphilis outbreak in homosexual men in east London. Sex Transm Infect 80(6):509–511PubMedCrossRefGoogle Scholar
  50. Hovind-Hougen K (1983) Morpholgy. In: Schell RF, Musher DM (eds) Pathogenesis and immunology of Treponemal infection. Marcel Dekker, Inc., New YorkGoogle Scholar
  51. Jackman JD Jr, Radolf JD (1989) Cardiovascular syphilis. Am J Med 87(4):425–433PubMedCrossRefGoogle Scholar
  52. Jepsen OB, Hougen KH, Birch-Andersen A (1968) Electron microscopy of Treponema pallidum Nichols. Acta Pathol Microbiol Scand 74(2):241–258PubMedCrossRefGoogle Scholar
  53. Kampmeier R (1964) The late manifestations of syphilis: skeletal, visceral and cardiovascular. Med Clin North Am 48:667–697Google Scholar
  54. Kevin S (2004) Venereal disease, hospitals and urban poor: London’s foul wards, 1600–1800. University of Rochester Press, RochesterGoogle Scholar
  55. LaFond RE, Centurion-Lara A, Godornes C, Rompalo AM, Van Voorhis WC, Lukehart SA (2003) Sequence diversity of Treponema pallidum subsp. pallidum tprK in human syphilis lesions and rabbit-propagated isolates. J Bacteriol 185(21):6262–6268PubMedCrossRefGoogle Scholar
  56. LaFond RE, Molini BJ, Van Voorhis WC, Lukehart SA (2006) Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis. Infect Immun 74(11):6244–6251PubMedCrossRefGoogle Scholar
  57. Leader BT, Hevner K, Molini BJ, Barrett LK, Van Voorhis WC, Lukehart SA (2003) Antibody responses elicited against the Treponema pallidum repeat proteins differ during infection with different isolates of Treponema pallidum subsp. pallidum. Infect Immun 71(10):6054–6057PubMedCrossRefGoogle Scholar
  58. Levinson G, Gutman GA (1987) Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol Biol Evol 4(3):203–221PubMedGoogle Scholar
  59. Liang FT, Jacobson RH, Straubinger RK, Grooters A, Philipp MT (2000) Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 38(11):4160–4166PubMedGoogle Scholar
  60. Lobdell J (1974) OD: the origin of syphilis. J Sex Res 10(1):4CrossRefGoogle Scholar
  61. Luger A (1993) The origin of syphilis. Clinical and epidemiologic considerations on the Columbian theory. Sex Transm Dis 20(2):110–117PubMedCrossRefGoogle Scholar
  62. Lukehart SA, Shaffer JM, Baker-Zander SA (1992) A subpopulation of Treponema pallidum is resistant to phagocytosis: possible mechanism of persistence. J Infect Dis 166(6):1449–1453PubMedCrossRefGoogle Scholar
  63. Magnuson HJ, Eagle H, Fleischman R (1948) The minimal infectious inoculum of Spirochaeta pallida (Nichols Strain), and a consideration of its rate of multiplication in vivo. Am J Syphilis 32(1):1–18Google Scholar
  64. Marra CM, Maxwell CL, Smith SL, Lukehart SA, Rompalo AM, Eaton M, Stoner BP, Augenbraun M, Barker DE, Corbett JJ et al (2004) Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189(3):369–376PubMedCrossRefGoogle Scholar
  65. Marra CM, Sahi SK, Tantalo LC, Godornes C, Reid T, Behets F, Rompalo A, Klausner JD, Yin YP, Mulcahy F et al (2010) Enhanced molecular typing of Treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis 202(9):1380–1388PubMedCrossRefGoogle Scholar
  66. Mascola L, Pelosi R, Blount JH, Alexander CE, Cates W Jr (1985) Congenital syphilis revisited. Am J Dis Child 139(6):575–580PubMedGoogle Scholar
  67. Matejkova P, Strouhal M, Smajs D, Norris SJ, Palzkill T, Petrosino JF, Sodergren E, Norton JE, Singh J, Richmond TA et al (2008) Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol 8:76PubMedCrossRefGoogle Scholar
  68. McGough LJ, Erbelding E (2006) Historical evidence of syphilis and other treponematosis. In: Radolf JD, Lukahart SA (eds) Pathogenic treponema—molecular and cellular biology. Caister Academic Press, Norfolk, EnglandGoogle Scholar
  69. Merritt HH, Adams RD, Solomon HC (1946) Neurosyphilis. Oxford University Press, New YorkGoogle Scholar
  70. Mindel A, Tovey SJ, Timmins DJ, Williams P (1989) Primary and secondary syphilis, 20 years’ experience. 2. Clinical features. Genitourin Med 65(1):1–3PubMedGoogle Scholar
  71. Morgan CA, Molini BJ, Lukehart SA, Van Voorhis WC (2002a) Segregation of B and T cell epitopes of Treponema pallidum repeat protein K to variable and conserved regions during experimental syphilis infection. J Immunol 169(2):952–957PubMedGoogle Scholar
  72. Morgan CA, Lukehart SA, Van Voorhis WC (2002b) Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model. Infect Immun 70(12):6811–6816PubMedCrossRefGoogle Scholar
  73. Morgan CA, Lukehart SA, Van Voorhis WC (2003) Protection against syphilis correlates with specificity of antibodies to the variable regions of Treponema pallidum repeat protein K. Infect Immun 71(10):5605–5612PubMedCrossRefGoogle Scholar
  74. Nell EE, Hardy PH (1966) Studies on the chemical composition and immunologic properties of a polysaccharide from the Reiter treponeme. Immunochemistry 3(3):233–245PubMedCrossRefGoogle Scholar
  75. Nichols HJ, Hough WH (1913) Demonstration of Spirochaeta pallida in the cerebrospinal fluid. JAMA 60:108–110CrossRefGoogle Scholar
  76. Oriel JD (2004) The scars of venus: a history of venerealogy. Springer, LondonGoogle Scholar
  77. Palmer GH, Bankhead T, Lukehart SA (2009) ‘Nothing is permanent but change’—antigenic variation in persistent bacterial pathogens. Cell Microbiol 11(12):1697–1705PubMedCrossRefGoogle Scholar
  78. Radolf JD (1995) Treponema pallidum and the quest for outer membrane proteins. Mol Microbiol 16(6):1067–1073PubMedCrossRefGoogle Scholar
  79. Radolf JD, Lukehart SA (eds) (2006) Pathogenic Treponema: molecular and cellular biology. Caister Academic Press, Norfolk, England.Google Scholar
  80. Radolf JD, Norgard MV (1988) Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114. Infect Immun 56(7):1825–1828PubMedGoogle Scholar
  81. Radolf JD, Chamberlain NR, Clausell A, Norgard MV (1988) Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114. Infect Immun 56(2):490–498PubMedGoogle Scholar
  82. Radolf JD, Norgard MV, Schulz WW (1989) Outer membrane ultrastructure explains the limited antigenicity of virulent Treponema pallidum. Proc Natl Acad Sci U S A 86(6):2051–2055PubMedCrossRefGoogle Scholar
  83. Radolf JD, Robinson EJ, Bourell KW, Akins DR, Porcella SF, Weigel LM, Jones JD, Norgard MV (1995) Characterization of outer membranes isolated from Treponema pallidum, the syphilis spirochete. Infect Immun 63(11):4244–4252PubMedGoogle Scholar
  84. Radolf JD, Sanchez PJ, Schultz KF, Murphy KM (1999) Congenital syphilis, chapter 84. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN (eds) Sexually transmitted diseases, 3rd edn. McGraw-Hill, New YorkGoogle Scholar
  85. Renton AM, Borisenko KK, Meheus A, Gromyko A (1998) Epidemics of syphilis in the newly independent states of the former Soviet Union. Sex Transm Infect 74(3):165–166PubMedCrossRefGoogle Scholar
  86. Rompalo AM, Joesoef MR, O’Donnell JA, Augenbraun M, Brady W, Radolf JD, Johnson R, Rolfs RT (2001) Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis 28(3):158–165PubMedCrossRefGoogle Scholar
  87. Rothschild B (2003) Infectious processes around the dawn of civilization. In: Greenblatt CL, Spigelman M (eds) Emerging pathogens: the archaeology, ecology, and evolution of infectious disease. Oxford University Press, LondonGoogle Scholar
  88. Rothschild BM, Calderon FL, Coppa A, Rothschild C (2000) First European exposure to syphilis: the Dominican Republic at the time of Columbian contact. Clin Infect Dis 31(4):936–941PubMedCrossRefGoogle Scholar
  89. Sarkari J, Pandit N, Moxon ER, Achtman M (1994) Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol 13(2):207–217PubMedCrossRefGoogle Scholar
  90. Saunders NJ, Peden JF, Hood DW, Moxon ER (1998) Simple sequence repeats in the Helicobacter pylori genome. Mol Microbiol 27(6):1091–1098PubMedCrossRefGoogle Scholar
  91. Sell S, Gamboa D, Baker-Zander SA, Lukehart SA, Miller JN (1980) Host response to Treponema pallidum in intradermally-infected rabbits: evidence for persistence of infection at local and distant sites. J Invest Dermatol 75(6):470–475PubMedCrossRefGoogle Scholar
  92. Sheffield JS, Sanchez PJ, Morris G, Maberry M, Zeray F, McIntire DD, Wendel GD Jr (2002) Congenital syphilis after maternal treatment for syphilis during pregnancy. Am J Obstet Gynecol 186(3):569–573PubMedCrossRefGoogle Scholar
  93. Simon RP (1994) Neurosyphilis. Neurology 44(12):2228–2230PubMedCrossRefGoogle Scholar
  94. Stamm LV, Bergen HL (2000) The sequence-variable, single-copy tprK gene of Treponema pallidum Nichols strain UNC and street strain 14 encodes heterogeneous TprK proteins. Infect Immun 68(11):6482–6486PubMedCrossRefGoogle Scholar
  95. Stokes JH, Beerman H, Ingram NR (1944) Modern clinical syphilology. W.B. Saunders, PhiladelphiaGoogle Scholar
  96. Sun ES, Molini BJ, Barrett LK, Centurion-Lara A, Lukehart SA, Van Voorhis WC (2004) Subfamily I Treponema pallidum repeat protein family: sequence variation and immunity. Microbes Infect 6(8):725–737PubMedCrossRefGoogle Scholar
  97. Temkin O (1977) The double face of janus and other essays on the history of medicine. Johns Hopkins University Press, BaltimoreGoogle Scholar
  98. Turner TB, Hollander DH (1957) Biology of the Treponematoses. World Health Organization, GenevaGoogle Scholar
  99. U.S. Department of Health, Education, and Welfare (1968) Syphilis—a synopsis. Center for Disease Control, Atlanta, GAGoogle Scholar
  100. Uhlenhuth PT (1913a) Weitere mitteilungen über die infectiosität des blutes und anderer körperflüssigkeiten syphilitischer menschen für das kaninchen. Berl klin Wchnschr 50:769–775Google Scholar
  101. Uhlenhuth PT (1913b) Weitere mitteilungen über ergebnisse der experimetnellen syphilisforschung. Berl klin Wchnschr 50:2031–2035Google Scholar
  102. van der Ende A, Hopman CT, Zaat S, Essink BB, Berkhout B, Dankert J (1995) Variable expression of class I outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the −10 and −35 regions of the promoter. J Bacteriol 177(9):2475–2480PubMedGoogle Scholar
  103. van der Woude MW, Baumler AJ (2004) Phase and antigenic variation in bacteria. Clin Microbiol Rev 17(3):581–611PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  1. 1.Department of Medicine, Division of Allergy and Infectious Diseases, Harborview Medical CenterUniversity of WashingtonSeattleUSA

Personalised recommendations